BCLIBrainStorm Cell TherapeuticsBCLI info
$2.04info-9.33%24h
Global rank20093
Market cap$99.92M
Change 7d31.61%
YTD Performance655.56%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    BrainStorm Cell Therapeutics (BCLI) Stock Overview

    Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

    BCLI Stock Information

    Symbol
    BCLI
    Address
    1325 Avenue of AmericasNew York, NY 10019United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.brainstorm-cell.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    201 488 0460

    BrainStorm Cell Therapeutics (BCLI) Price Chart

    -
    Value:-

    BrainStorm Cell Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.04
    N/A
    Market Cap
    $99.92M
    N/A
    Shares Outstanding
    48.98M
    N/A
    Employees
    42.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org